Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_assertion type Assertion NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_head.
- NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_assertion description "[Previously, we had observed that more than 80% of clear cell renal carcinomas (RCCs) exhibited loss of heterozygosity (LOH) between the microsatellite markers D3S1285 (in 3p14.1) and D3S1295 (in 3p21.1), a region which includes the protein tyrosine phosphatase gamma locus (PTPRG locus, PTP gamma gene) and the 3p14.2 break of the familial RCC-associated translocation, t(3;8)(p14.2;q24), which has been hypothesized to affect expression of an RCC suppressor gene or oncogene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_provenance.
- NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_assertion evidence source_evidence_literature NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_provenance.
- NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_assertion SIO_000772 7585599 NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_provenance.
- NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_assertion wasDerivedFrom befree-20140225 NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_provenance.
- NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_assertion wasGeneratedBy ECO_0000203 NP277168.RA263kRE-b2qELVCqm7HS3jxHb6e84Pk2NTqTTdcJkSTg130_provenance.